Mumbai, Sept. 18 -- Natco Pharma announced that on conclusion of the USFDA inspection, it has received Establishment Inspection Report (EIR) classifying the company's pharma division located at Kothur, Hyderabad as "Voluntary Action Indicated (VAI)".

Published by HT Digital Content Services with permission from Capital Market....